Johnson & Johnson Loses Another Talc-Powder Trial, Ordered To Pay $55 Million To Cancer Patient
Johnson & Johnson has been ordered by a United States jury on Monday to pay $55 million. This is concerning a woman who said that using the company’s talc-powder products for feminine hygiene caused her to develop ovarian cancer.